Psyence Biomedical (PBM) Income from Continuing Operations (2023 - 2025)
Psyence Biomedical's (PBM) quarterly Income from Continuing Operations came in at 1504977.0 in Q3 2025, down 230.18% year-on-year from 1156102.0 in Q3 2024, and down 230.18% quarter-over-quarter from 1156102.0 in Q3 2024.
Psyence Biomedical (PBM) Income from Continuing Operations (2023 - 2025) Analysis & Trends
Psyence Biomedical's Income from Continuing Operations history runs 3 years deep, the most recent figure standing at 1504977.0 for Q3 2025.
- On a quarterly basis, Income from Continuing Operations fell 230.18% year-over-year to 1504977.0 in Q3 2025; TTM through Sep 2025 was 3759909.0, a N/A change from a year earlier, with the FY2026 full-year figure at 6232245.0, down 70.34% from the prior year.
- Income from Continuing Operations eased to 1504977.0 in Q3 2025 per PBM's latest filing, from 1156102.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 1156102.0 in Q3 2024 and bottomed at 3234869.0 in Q1 2023.
- The 3-year median for Income from Continuing Operations is 840571.0 (2023), against an average of 939977.25.
- Across the five-year window, Income from Continuing Operations surged 756.26% in 2024 and tumbled 230.18% in 2025, its largest moves.
- Year by year, Income from Continuing Operations stood at 176165.0 in 2023, then jumped by 756.26% to 1156102.0 in 2024, then tumbled by 230.18% to 1504977.0 in 2025.
- Per Business Quant, the three latest PBM Income from Continuing Operations figures stand at 1504977.0 (Q3 2025), 1156102.0 (Q3 2024), and 176165.0 (Q3 2023).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -37.09 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.68 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 727.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Psyence Biomedical | 1.56 Mn | 1.56 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1.50 Mn |
| Sep 30, 2024 | 1.16 Mn |
| Sep 30, 2023 | -176,165.00 |
| Mar 31, 2023 | -3.23 Mn |